Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Ransomware attack on DaVita exposes data from 2.7M

    25. August 2025

    Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI

    25. August 2025

    Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

    25. August 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»ARCHIMED Acquires a Majority Stake in Arkstone
    Health

    ARCHIMED Acquires a Majority Stake in Arkstone

    HealthradarBy Healthradar31. Juli 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    ARCHIMED Acquires a Majority Stake in Arkstone
    Share
    Facebook Twitter LinkedIn Pinterest Email


    What You Should Know: 

    – Arkstone, a pioneer in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical decision support and antimicrobial stewardship has been acquired by ARCHIMED, a private equity firm specializing in the healthcare sector. Financial details of the acquisition were not disclosed. 

    – The acquisition marks a pivotal moment in Arkstone’s growth trajectory, positioning the company to expand its global footprint, deepen its R&D capabilities, and bring its precision-guided technology to more clinicians worldwide.

    – Backed by ARCHIMED’s capital, extensive healthcare expertise, and international reach, Arkstone is poised to scale its impact on the global fight against antimicrobial resistance (AMR), one of the most urgent public health threats of our time.

    Redefining Infectious Disease Management with AI

    The global fight against antimicrobial resistance is a critical public health challenge. Arkstone’s flagship OneChoice Report leverages human-in-the-loop ML and AI to generate optimal infectious disease treatment recommendations. It achieves this by analyzing laboratory results alongside patient data, delivering patient-specific guidance to clinicians at the moment lab results are received. Already in use by laboratories across the United States and internationally, Arkstone is transforming how healthcare providers diagnose, treat, and understand infectious diseases.

    Following the acquisition, Arkstone will continue to operate with its existing team. The company’s next phase will focus on rapid growth, further product development, and entry into new markets.

    “Arkstone’s OneChoice Report is redefining infectious disease management. Our partnership will enable Arkstone to reach more markets, accelerate product innovation, and ultimately save lives by reducing the misuse of antibiotics,” said Igor Petricca, Partner at ARCHIMED. “This deal offers an additional dimension, as Clinical Decision Support software (CDS) and infectious disease are at the crossroads of hot subsectors of our Healthcare IT and Diagnostics franchises.”



    Source link

    acquires ARCHIMED Arkstone Healthcare Mergers & Acquisitions Majority Stake
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleSheba Medical Center and ARC Launch Space Experiment to Study Bacterial Behavior
    Next Article MAUI Imaging Secures $14M, Unveils Patented CET Ultrasound for Unseen Anatomy
    ekass777x
    Healthradar
    • Website

    Related Posts

    Health

    restor3d Announces Strategic Investment Partnership with Partners Group to Accelerate Growth in Personalized Orthopedic Solutions

    25. August 2025
    Health

    In the Heart of London Finance, Canary Wharf Becomes a Swim Spot

    25. August 2025
    Health

    She’s bracing and saving to pay $2,800 a month for ACA health insurance next year

    25. August 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202540 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202519 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202517 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20259 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202540 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202519 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.